Eyal Attar

Plus aucun poste en cours

55 ans

Health Technology

Consumer Services

Profil

Eyal C.
Attar formerly worked at Agios Pharmaceuticals, Inc., as Senior Medical Director from 2016 to 2019, Harvard Medical School, as Member-Leukemia Center, Aprea Therapeutics, Inc., as Chief Medical Officer & Senior Vice President, and Vor Biopharma, Inc., as Chief Medical Officer from 2022 to 2025.
Dr. Attar received his doctorate degree from UNC School of Medicine.

Anciens postes connus de Eyal Attar

Sociétés	Poste	Fin
VOR BIOPHARMA INC.	Directeur Technique/Scientifique/R&D	18/04/2025
AGIOS PHARMACEUTICALS, INC.	Directeur Technique/Scientifique/R&D	01/01/2019
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
APREA THERAPEUTICS, INC.	Directeur Technique/Scientifique/R&D	-

Voir l'expérience en détail de Eyal Attar

Formation de Eyal Attar

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Eyal Attar

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	5
Agios Pharmaceuticals, Inc. Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics	Health Technology
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
UNC School of Medicine UNC School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vor Biopharma, Inc. Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies	Health Technology
Aprea Therapeutics, Inc. Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds	Health Technology